More recently, Thwaites, RS et al. discovered a progressive elevation of GM-CSF, CXCL10/IP-10 and IL-6 levels in some COVID-19 patients with severe thrombosis (Thwaites et al. 2021). This evidence concerns the gene IL6 and COVID-19.